The effect of Tabex (cytisine) on success of attempts to stop smoking

促进戒烟可能是减少癌症的唯一最重要的目标。有几种药物可以帮助，心理支持也很有效。有机会评估一种在东欧使用多年的药物（Tabex），它是通用的，生产成本低？它的成本不到目前药物的五分之一。这将对英国吸烟者、国民保健制度以及可能更重要的是对海外低收入吸烟者有相当大的好处。拟议的严格试验将在波兰进行，并将体现出非同寻常的资金价值。将通过与MHRA和其他相关监管机构讨论，以建立许可证发放的基础，推进研究结果。一旦论文在适当的同行审查期刊上被打上批注，审查结果也将通过适当的新闻办公室传播。

Promoting smoking cessation is probably the single most important goal in reducing cancer. There are several drugs that can help, and psychological support is also effective. There is an opportunity to evaluate a drug (Tabex) that has been in use in Eastern Europe for many years, is generic and cheap to manufacture ? so much so that it costs less than one fifth of current medications. This would be of considerable benefit to UK smokers, the NHS and perhaps more importantly to low income smokers overseas. The proposed rigorous trial would be conducted in Poland and would represent exceptional value for money.The findings will be taken forward through discussion with the MHRA and other relevant regulatory bodies to establish a basis for licensing. The results will also be dissemintated through appropriate press offices once a paper has been punlished in an appropriate peer review journal.